MX2020007391A - Nuevo galactosido inhibidor de galectinas. - Google Patents
Nuevo galactosido inhibidor de galectinas.Info
- Publication number
- MX2020007391A MX2020007391A MX2020007391A MX2020007391A MX2020007391A MX 2020007391 A MX2020007391 A MX 2020007391A MX 2020007391 A MX2020007391 A MX 2020007391A MX 2020007391 A MX2020007391 A MX 2020007391A MX 2020007391 A MX2020007391 A MX 2020007391A
- Authority
- MX
- Mexico
- Prior art keywords
- galectins
- formula
- galectin
- sup
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
La presente invención se refiere a un compuesto de la fórmula general (1). El compuesto de la fórmula (1) es adecuado para el uso en un método para tratar un trastorno relacionado con la unión de una galectina, tal comogalectina-1 a un ligando en un mamífero, tal como un humano. Además, la presente invención se refiere a un método para el tratamiento de un trastorno relacionado con la unión de una galectina, tal como galectina-1 a un ligando en un mamífero, tal como un humano.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18150959 | 2018-01-10 | ||
| PCT/EP2019/050467 WO2019137971A1 (en) | 2018-01-10 | 2019-01-09 | Novel galactoside inhibitor of galectins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020007391A true MX2020007391A (es) | 2020-09-03 |
Family
ID=60953765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020007391A MX2020007391A (es) | 2018-01-10 | 2019-01-09 | Nuevo galactosido inhibidor de galectinas. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11046725B2 (es) |
| EP (1) | EP3737686A1 (es) |
| JP (1) | JP2021510692A (es) |
| KR (1) | KR20200108303A (es) |
| CN (1) | CN111699193A (es) |
| BR (1) | BR112020013647A2 (es) |
| CA (1) | CA3086092A1 (es) |
| EA (1) | EA202091684A1 (es) |
| MX (1) | MX2020007391A (es) |
| WO (1) | WO2019137971A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2858729T3 (es) | 2015-01-30 | 2021-09-30 | Galecto Biotech Ab | Inhibidores de alfa-d-galactósido de galectinas |
| EA202091684A1 (ru) * | 2018-01-10 | 2020-12-04 | Галекто Биотек Аб | Новый галактозидный ингибитор галектинов |
| CN113366007A (zh) * | 2018-10-15 | 2021-09-07 | 格莱克特生物技术公司 | 半乳糖凝集素的半乳糖苷抑制剂 |
| JP2022538635A (ja) * | 2019-07-03 | 2022-09-05 | ガレクト バイオテック エービー | ガレクチンの新規なガラクトシド阻害剤 |
| TW202134214A (zh) * | 2020-03-04 | 2021-09-16 | 瑞士商先正達農作物保護公司 | 用於製備具有3-含硫取代基的5-氯-吡啶-2-甲酸醯胺以及甲酸鹽之方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6849607B2 (en) | 2001-05-09 | 2005-02-01 | Health Research, Inc. | Galectin recognized photosensitizers for photodynamic therapy |
| SE0401301D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| ES2652488T3 (es) | 2009-04-28 | 2018-02-02 | Galecto Biotech Ab | Nuevos inhibidores de galactósidos de galectinas |
| MX363178B (es) | 2012-10-10 | 2019-03-13 | Galectin Therapeutics Inc | Compuestos de carbohidratos con funcion de galactosa para el tratamiento de la nefropatia diabetica y de los trastornos asociados. |
| CA2884802A1 (en) | 2012-10-31 | 2014-05-08 | Galecto Biotech Ab | Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis |
| ES2776255T3 (es) * | 2015-01-16 | 2020-07-29 | Galecto Biotech Ab | Novedoso inhibidor de galactósido de galectinas |
| ES2858729T3 (es) | 2015-01-30 | 2021-09-30 | Galecto Biotech Ab | Inhibidores de alfa-d-galactósido de galectinas |
| EP3484903A1 (en) * | 2016-07-12 | 2019-05-22 | Galecto Biotech AB | Alpha-d-galactoside inhibitors of galectins |
| US10889610B2 (en) * | 2016-07-12 | 2021-01-12 | Galecto Biotech Ab | Alpha-D-galactoside inhibitors of galectins |
| EA202091684A1 (ru) * | 2018-01-10 | 2020-12-04 | Галекто Биотек Аб | Новый галактозидный ингибитор галектинов |
-
2019
- 2019-01-09 EA EA202091684A patent/EA202091684A1/ru unknown
- 2019-01-09 MX MX2020007391A patent/MX2020007391A/es unknown
- 2019-01-09 CA CA3086092A patent/CA3086092A1/en active Pending
- 2019-01-09 EP EP19700281.9A patent/EP3737686A1/en not_active Withdrawn
- 2019-01-09 WO PCT/EP2019/050467 patent/WO2019137971A1/en unknown
- 2019-01-09 JP JP2020538084A patent/JP2021510692A/ja active Pending
- 2019-01-09 CN CN201980007910.3A patent/CN111699193A/zh active Pending
- 2019-01-09 BR BR112020013647-6A patent/BR112020013647A2/pt not_active Application Discontinuation
- 2019-01-09 US US16/960,996 patent/US11046725B2/en active Active
- 2019-01-09 KR KR1020207022591A patent/KR20200108303A/ko unknown
-
2021
- 2021-05-24 US US17/327,954 patent/US11827666B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11046725B2 (en) | 2021-06-29 |
| CA3086092A1 (en) | 2019-07-18 |
| KR20200108303A (ko) | 2020-09-17 |
| US20210284678A1 (en) | 2021-09-16 |
| BR112020013647A2 (pt) | 2020-12-01 |
| JP2021510692A (ja) | 2021-04-30 |
| US11827666B2 (en) | 2023-11-28 |
| US20200347089A1 (en) | 2020-11-05 |
| EA202091684A1 (ru) | 2020-12-04 |
| CN111699193A (zh) | 2020-09-22 |
| EP3737686A1 (en) | 2020-11-18 |
| WO2019137971A1 (en) | 2019-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020007391A (es) | Nuevo galactosido inhibidor de galectinas. | |
| EP3828191A3 (en) | Novel galactoside inhibitor of galectins | |
| PH12020551795A1 (en) | C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors | |
| MX2023007581A (es) | Analogos de rapamicina unidos a c26 como inhibidores de mtor. | |
| MX2022001295A (es) | Inhibidores de kif18a. | |
| TW200637866A (en) | Amino-imidazolones for the inhibition of β-secretase | |
| MX2023000025A (es) | Inhibidores de la quinasa progenitora hematopoyética 1 y usos de estos. | |
| NZ746554A (en) | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | |
| MX2010001565A (es) | Compuestos triazolicos que modulan la actividad de proteina de choque termico (hsp) 90. | |
| MX2009008547A (es) | Compuestos de triazol que son utiles en el tratamiento de trastornos proliferativos tales como cancer. | |
| UA95298C2 (ru) | Фенилзамещенные гетероарильные производные и их применение в качестве противоопухолевых средств | |
| TW200639166A (en) | Amino-pyridines as inhibitors of β-secretase | |
| WO2010058032A3 (en) | Substituted pyrimidines for the treatment of diseases such as cancer | |
| TW200630374A (en) | Thiazolyldihydroindazoles | |
| MX2021014350A (es) | Compuestos de 1-oxo-isoindolin-5-carboxamida sustituida, composiciones de los mismos y metodos de tratamiento con los mismos. | |
| GEP20146138B (en) | Method for treating androgen receptor positive cancers | |
| MX2021000941A (es) | Compuestos de pirimidina y composiciones farmaceuticas para prevenir o tratar canceres que incluyen los mismos. | |
| SG11201903875QA (en) | Selective inhibitor of exon 20 insertion mutant egfr | |
| MX340870B (es) | Compuestos de unión del dominio de repetición de inhibidores de proteínas de apoptosis de baculovirus. | |
| WO2010075280A3 (en) | Coumarin-based compounds for the treatment of alzheimer's disease and cancer | |
| CR20220116A (es) | Compuestos heterocíclicos | |
| MX2010004017A (es) | 5-cianotienopiridinas para el tratamiento de tumores. | |
| MX2020008678A (es) | Metodos de uso para derivados de benzotriazol trisustituidos. | |
| CR20220004A (es) | Nuevos compuestos heterocíclicos | |
| MX2020008746A (es) | Compuestos de sulfonimidoilpurinona 7-sustituidos y sus derivados para el tratamiento y prevencion del cancer de higado. |